Oncoinvent

Developer of radioisotope-based anti-cancer therapeutics

placeOslo, Oslo, Norway calendar_todayFounded 2010 groups27 employees language oncoinvent.com

Registered entities

Social engagement

Social engagement: 3.8K social following, 10 posts in the last 12 months — top quartile of its industry.

Investor mix

10 investors on record; lead investors include Hadean Ventures, Canica, Mitas.

Investor typeCountShare
Venture capital440%
Private equity110%
Other / undisclosed550%

Recent activity

18 Jun 2026
Milestone
regulatory
16 Jun 2026
Event
BIO International Convention 2026
22 May 2026
Event
Rottschild & Co Redburn Radiopharma Conference 2026
Coming soon